Agoracom: Small Cap Investment - Chitogenx Inc. - SmallCap 60: Recent Patent Is Key Value Creation Milestone For Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB)

Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Reply New Message

Back To Forum List View

AGORACOM-BM

Rank: Administrator [?]

Points: 25775 [?]

Votes: 3 Score: 5.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

SmallCap 60: Recent Patent Is Key Value Creation Milestone For Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB)

posted on May 17, 2022 10:55AM

Reply New Message

Back To Forum List View

Please to post a reply